The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.
The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
The Prix Galien rewards excellence and novelty, and awards additional honors to those who show great promise in the fields of innovative therapeutics, and who have served humanity at large.
The pharmaceutical, biotechnology,diagnostics and medical device products considered for the Prix Galien USA Award must be fully FDA approved, (provisional approvals are not sufficient) and shall have been based on innovative science, developed by synthetic chemistry or molecular biology, manufactured to precise specifications, tested in controlled clinical trials and marketed by ethical pharmaceutical companies.
The committee will award three prizes for therapeutics: the Best Pharmaceutical Agent (i.e. small molecule), the Best Biotechnology Product, and the Best Medical Device or Diagnostic approved in the USA in the past five years.
As to the science, candidates will be chosen from among all therapeutic categories-- and each will be judged against all of the others.
The prizes will be awarded for pharmaceutical science that improves the human condition, principally based on two criteria:One: What was innovative in the course of this product’s scientific development, application or clinical utility?Two: What was learned for the future of biomedical science from this product’s introduction to the clinic?The Pro Bono Humanum Award Previous